Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors

NCT01482156 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors
Metastatic Breast Cancer
Metastatic Renal Cell Carcinoma

Interventions

DRUG: RAD001 + BEZ235

Sponsor

Novartis Pharmaceuticals